ORIGINAL RESEARCH
Accepted on 16 Oct 2025
Targeting Pin1 to Overcome Immunosuppressive Tumor Microenvironment in MSS Colorectal Cancer
doi 10.3389/fimmu.2025.1677029
- 122 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Checkpoint immunotherapy: Reshaping the landscape of gastrointestinal cancer treatment - Volume II
Checkpoint immunotherapy: Reshaping the landscape of gastrointestinal cancer treatment - Volume II
414
Total downloads
3,168
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Published on 15 Oct 2025
First-line immune checkpoint inhibitors plus targeted therapy versus sorafenib or lenvatinib monotherapy for unresectable or advanced hepatocellular carcinoma: a meta-analysis of phase 3 trials
doi 10.3389/fimmu.2025.1667793
- 343 views
ORIGINAL RESEARCH
Accepted on 07 Oct 2025
Residual pattern of primary tumor and lymph node in ESCC treated with nCRT with or without pembrolizumab: an analysis from a prospective cohort
doi 10.3389/fimmu.2025.1700400
- 271 views
CASE REPORT
Published on 30 Sep 2025
Efficacy of cadonilimab in combination with nimotuzumab and AG regimen in TMB-H/KRAS wild-type advanced pancreatic cancer: a case report
doi 10.3389/fimmu.2025.1652827
- 540 views
ORIGINAL RESEARCH
Published on 13 Aug 2025
Preexisting ulcerative colitis increases the risk of immune-related colitis and predicts divergent survival outcomes in gastrointestinal cancer patients treated with immune checkpoint inhibitors
doi 10.3389/fimmu.2025.1627680
- 1,068 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: